Impotens forårsaget af behandling med methotrexat

Elisabeth I. Penninga, Helle Kiellberg Larsen, Stig Ejdrup Andersen

    Publikation: Bidrag til tidsskriftArtikelForskningpeer review


    Methotrexate (MTX) is used in the treatment of malignant and non-malignant diseases. This case report describes impotence as a seldom but possible overlooked adverse effect to MTX treatment. A 58-year-old man was treated for erythrodermia with a weekly dose of 7.5 mg MTX. He developed erective impotence 9 months after initiation of treatment. Two weeks after discontinuation of MTX the impotence subsided, but when MTX treatment was reintroduced, the impotence returned after two months. Only a few other cases of impotence associated with MTX have been described previously.

    Bidragets oversatte titelImpotence caused by Methotrexate treatment
    Antal sider1
    TidsskriftUgeskrift for laeger
    Udgave nummer5
    StatusUdgivet - 28 jan. 2008


    Udforsk hvilke forskningsemner 'Impotens forårsaget af behandling med methotrexat' indeholder.